European Journal of Heart Failure

FEBRUARY 23, 2024

Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality.

Cardiogenic Shock 75

Cardiogenic Shock Myocardial Infarction Article 75

Cardiology Update

JUNE 4, 2024

The post DanGer Shock: Microaxial Flow Pump versus Standard Care in Infarct-Related Cardiogenic Shock appeared first on Cardiology Update. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram.

Cardiogenic Shock 108

Cardiogenic Shock Myocardial Infarction Research Circulation 108

JAMA Cardiology

OCTOBER 26, 2024

In a seminal case series published in 1967, Killip and Kimball reported 81% in-hospital mortality for patients presenting with acute myocardial infarction complicated by cardiogenic shock (AMI-CS).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Heart Failure Hospital 40

Circulation

NOVEMBER 11, 2024

Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes. Patients without CHD were older (mean age 71.5

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

American College of Cardiology

SEPTEMBER 13, 2024

The goal of the ECLS-SHOCK trial was to evaluate extracorporeal life support (ECLS) compared with control among patients with acute myocardial infarction (MI) and cardiogenic shock.

Cardiogenic Shock 48

Cardiogenic Shock Myocardial Infarction Article 48

American College of Cardiology

FEBRUARY 1, 2024

What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?

Cardiogenic Shock 66

Cardiogenic Shock Outcomes Heart Failure Hospital 66

Medical Xpress - Cardiology

DECEMBER 13, 2023

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

Cardiogenic Shock 71

Cardiogenic Shock Heart Attack Heart attacks Hospital 71

Nature Reviews - Cardiology

APRIL 22, 2024

Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01035-9 Data from the DanGer Shock trial demonstrate that implantation of a microaxial flow pump in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock increases the survival rate compared with standard care alone.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Myocardial Infarction 52

Circulation

FEBRUARY 26, 2024

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

The New England Journal of Medicine

MARCH 13, 2024

An evaluation showed 2-mm ST-segment elevations in the inferior leads on electrocardiography, cardiogenic shock, and a new systolic murmur. A 55-year-old man had an out-of-hospital cardiac arrest. A diagnosis was made.

Cardiogenic Shock 75

Cardiogenic Shock Cardiac Arrest Hospital 75

American College of Cardiology

APRIL 7, 2024

Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results of the DanGer Shock study.

Cardiogenic Shock 58

Cardiogenic Shock STEMI Article 58

American College of Cardiology

AUGUST 31, 2024

Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation, with little change thereafter, according to a study by the Cardiogenic Shock Working Group (CSWG) presented at ESC Congress 2024 in London and simultaneously published in JACC.

Cardiogenic Shock 40

Cardiogenic Shock Article 40

American College of Cardiology

MARCH 12, 2024

The following are key points to remember from an American Heart Association Scientific Statement on cardiogenic shock (CS) in older adults, which focuses on age-associated risks and approach to management.

Cardiogenic Shock 44

Cardiogenic Shock Article 44

The New England Journal of Medicine

APRIL 6, 2024

Acute myocardial infarction–related cardiogenic shock (AMI-CS) is characterized by systemic hypoperfusion due to cardiomyocyte necrosis and ventricular dysfunction.1 2 Prompt reperfusion.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Hospital 40

American College of Cardiology

JUNE 25, 2024

Cardiogenic shock is a common complication in patients who present with acute myocardial infarction (AMI) and is the leading cause of death in this population. Even with immediate revascularization, death rates remain high.

Cardiogenic Shock 56

Cardiogenic Shock Myocardial Infarction Article 56

American College of Cardiology

SEPTEMBER 11, 2024

In this week’s View, Dr. Eagle looks at temporary mechanical circulatory support in infarct-related cardiogenic shock.

Cardiogenic Shock 51

Cardiogenic Shock AFIB Article 51

Dr. S. Venkatesan MD

DECEMBER 29, 2023

Cardiogenic shock (CS)is the most feared event following STEMI. Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes. The incidence is up to 5 to 10% with a mortality rate of around 50-60%. Still, we are finding it hard to bring this down below 50 %. Reference 1.Martínez J Clin Med.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Myocardial Infarction Outcomes 52

ECG Cases

JANUARY 4, 2022

What is the preferred order of vasopressors and ionotropes in the management of cardiogenic shock? How can we best pick up occult cardiogenic shock before it floured shock kicks in? The post Ep 164 Cardiogenic Shock Simplified appeared first on Emergency Medicine Cases.

Cardiogenic Shock 52

Cardiogenic Shock Heart Failure Aortic Stenosis 52

Frontiers in Cardiovascular Medicine

OCTOBER 13, 2024

BackgroundIn the ICU, patients with acute myocardial infarction and cardiogenic shock (AMI-CS) often face high mortality rates, making timely and precise mortality risk prediction crucial for clinical decision-making.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction ICU 52

Journal of Cardiothoracic Surgery

FEBRUARY 2, 2024

Temporary mechanical circulatory support is a treatment of choice for patients in severe cardiogenic shock. Combining veno-arterial extracorporeal life support (ECLS) with devices that enable left ventricular.

Cardiogenic Shock 52

Cardiogenic Shock 52

JAMA Cardiology

AUGUST 6, 2024

This case report discusses progressive cardiogenic shock in a man aged 78 years after catheter ablation for ventricular tachycardia.

Cardiogenic Shock 40

Cardiogenic Shock Ablation Tachycardia 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. ConclusionsIn patients with cardiogenic shock on VA‐ECMO, LVU with Impella, particularly with 2.5/CP, Journal of the American Heart Association, Ahead of Print. and 16.4%, respectively.

Cardiogenic Shock 65

Cardiogenic Shock Aortic Hospital Outcomes 65

Science Daily - Heart Disease

AUGUST 30, 2023

The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock. A recent clinical trial has shown that extracorporeal life support (ECLS) does not reduce 30-day mortality after cardiogenic shock. The finding is likely to influence future guidelines.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure 40

Circulation

NOVEMBER 11, 2024

Background:Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is used to treat cardiogenic shock. Conclusion:An LV support device may be associated with reduced mortality and increased success in weaning off VA-ECMO in patients with cardiogenic shock. to 1.36) but not in VA-ECMO with IABP (1.80

Cardiogenic Shock 40

Cardiogenic Shock Pulmonary Aortic Circulation 40

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundClinical outcome of ischemic cardiogenic shock (CS) requiring extracorporeal membrane oxygenation is highly variable, necessitating appropriate assessment of prognosis. However, a systemic predictive model estimating the mortality of refractory ischemic CS is lacking.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

Medical Xpress - Cardiology

MAY 2, 2024

A nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) who underwent transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) determined that patients who underwent TAVR had lower in-hospital complications and resource utilization compared with SAVR.

Cardiogenic Shock 40

Cardiogenic Shock TAVR Stenosis Aortic 40

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundAcute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is associated with significant morbidity and mortality.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Blood Pressure Cardiac Arrest 40

Journal of the American Heart Association

MARCH 8, 2024

Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades. A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes.

Cardiogenic Shock 40

Cardiogenic Shock Best Practices Outcomes Education 40

European Journal of Heart Failure

DECEMBER 13, 2023

Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Hospital 40

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% The incidence of the primary safety outcome was 10.1% 1.09];P=0.08).CONCLUSIONS:In

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Circulation

NOVEMBER 11, 2024

Background:Various temporary mechanical circulatory support device (t-MCS) options are available for supporting patients in cardiogenic shock. Circulation, Volume 150, Issue Suppl_1 , Page A4143363-A4143363, November 12, 2024. and 4 bridged with IABP.

Cardiogenic Shock 40

Cardiogenic Shock Cancer Heart Failure Physiology 40

Frontiers in Cardiovascular Medicine

APRIL 16, 2024

We present a case of a 15-year-old male who developed fulminant myocarditis, cardiogenic shock, and cardiac electrical storm attributed to M. However, in rare instances, it can lead to extrapulmonary manifestations, including myocarditis. pneumoniae infection.

Cardiogenic Shock 52

Cardiogenic Shock Embolism Aortic Strokes 52

HeartRhythm

APRIL 30, 2024

Electrical storm (ES) complicated by cardiogenic shock (CS) is associated with high risk of morbidity and mortality.

Cardiogenic Shock 40

Cardiogenic Shock Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is a common sequela in cardiogenic shock (CS) and portends a worse prognosis. Despite its potential to worsen shock, no large-scale studies have investigated the impact of CV on patient outcomes. Electrical cardioversion (CV) is often employed for sinus rhythm restoration.

Cardiogenic Shock 40

Cardiogenic Shock Atrial Fibrillation Outcomes 40

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (ECMO) provides full hemodynamic support for patients with cardiogenic shock, but optimal timing of ECMO initiation remains uncertain.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Cardiac Arrest Hospital 40

Dr. Smith's ECG Blog

MAY 26, 2023

A 20-something presented after a huge verapamil overdose in cardiogenic shock. Today's patient is a young male who presented in cardiogenic shock following a massive verapamil overdose. He had been seen at an outside institution and been given 6 g calcium gluconate, KCl, and a norepinephrine drip. The initial K was 3.0

Cardiogenic Shock 88

Cardiogenic Shock Arrhythmia Blog Education 88

European Journal of Heart Failure

NOVEMBER 23, 2023

Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock. ACHF-CS, acute-on-chronic failure-related cardiogenic shock; CI, confidence interval; DNHF-CS, de novo heart failure-related cardiogenic shock; HR, hazard ratio.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Blood Pressure Outcomes 40